Michael Arenberg
Director de Operaciones en IMAGO BIOSCIENCES, INC. .
Cargos activos de Michael Arenberg
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Director de Operaciones | 23/03/2022 | - |
Historial de carrera de Michael Arenberg
Antiguos cargos conocidos de Michael Arenberg.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DURECT CORPORATION | Director Financiero/CFO | 15/10/2018 | 17/03/2022 |
| Contacto de Relaciones con Inversores | 01/01/1999 | 17/03/2022 | |
| Corporate Officer/Principal | 17/07/2009 | 15/10/2018 | |
| Secretario Corporativo | - | 17/03/2022 | |
IntraEAR, Inc.
 IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Fundador | 01/01/1996 | 01/01/1999 |
| Ventas & Marketing | 01/01/1996 | 01/01/1999 |
Formación de Michael Arenberg.
| University of Denver | Graduate Degree |
| Leavey School of Business | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
IntraEAR, Inc.
IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Arenberg
- Experiencia
